These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 25885915)

  • 1. Methotrexate: should it still be considered for chronic calcium pyrophosphate crystal disease?
    Pascual E; Andrés M; Sivera F
    Arthritis Res Ther; 2015 Apr; 17(1):89. PubMed ID: 25885915
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current advances in therapies for calcium pyrophosphate crystal arthritis.
    Sivera F; Andrés M; Pascual E
    Curr Opin Rheumatol; 2016 Mar; 28(2):140-4. PubMed ID: 26780424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate is an option for patients with refractory calcium pyrophosphate crystal arthritis.
    Andres M; Sivera F; Pascual E
    J Clin Rheumatol; 2012 Aug; 18(5):234-6. PubMed ID: 22832286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating difficult crystal pyrophosphate dihydrate deposition disease.
    Announ N; Guerne PA
    Curr Rheumatol Rep; 2008 Jul; 10(3):228-34. PubMed ID: 18638432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating CPPD crystal deposition, an important disease of aging.
    Bonafede RP
    Geriatrics; 1988 Nov; 43(11):59-64, 68. PubMed ID: 2846412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calcium pyrophosphate dihydrate crystal induced arthropathy].
    Announ N; Guerne PA
    Rev Med Suisse; 2007 Mar; 3(103):740-2, 744, 746. PubMed ID: 17458152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crystal arthritis: calcium pyrophosphate deposition-nothing 'pseudo' about it!
    Rosenthal AK; Ryan LM
    Nat Rev Rheumatol; 2011 May; 7(5):257-8. PubMed ID: 21532639
    [No Abstract]   [Full Text] [Related]  

  • 8. Destructive pseudo-neuroarthropathy associated with calcium pyrophosphate deposition.
    Lomax A; Ferrero A; Cullen N; Goldberg A; Singh D
    Foot Ankle Int; 2015 Apr; 36(4):383-90. PubMed ID: 25416203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging characteristics of calcium pyrophosphate dihydrate crystal deposition disease.
    Lin YY; Wang TG; Li KJ; Lew HL
    Am J Phys Med Rehabil; 2014 Mar; 93(3):272-3. PubMed ID: 22561381
    [No Abstract]   [Full Text] [Related]  

  • 10. Update in calcium deposition diseases.
    Rosenthal AK
    Curr Opin Rheumatol; 2007 Mar; 19(2):158-62. PubMed ID: 17278931
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and treatment of calcium pyrophosphate crystal-induced arthropathy].
    Announ N; Guerne PA
    Z Rheumatol; 2007 Nov; 66(7):573-4, 576-8. PubMed ID: 17932681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Calcium pyrophosphate deposition disease].
    Richette P; Bardin T
    Presse Med; 2011 Sep; 40(9 Pt 1):856-64. PubMed ID: 21684108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium Pyrophosphate Deposition Disease.
    Rosenthal AK; Ryan LM
    N Engl J Med; 2016 Jun; 374(26):2575-84. PubMed ID: 27355536
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate as an alternative therapy for chronic calcium pyrophosphate deposition disease: an exploratory analysis.
    Chollet-Janin A; Finckh A; Dudler J; Guerne PA
    Arthritis Rheum; 2007 Feb; 56(2):688-92. PubMed ID: 17265505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyrophosphate arthropathy as a late complication of juvenile chronic arthritis.
    Doherty M; Dieppe PA
    J Rheumatol; 1984 Apr; 11(2):219-21. PubMed ID: 6327981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention, safety and efficacy of off-label conventional treatments and biologics for chronic calcium pyrophosphate crystal inflammatory arthritis.
    Damart J; Filippou G; Andrès M; Cipolletta E; Sirotti S; Carboni D; Filippucci E; Diez P; Abhishek A; Latourte A; Ea HK; Ottaviani S; Letarouilly JG; Desbarbieux R; Graf S; Norberciak L; Richette P; Pascart T
    Rheumatology (Oxford); 2024 Feb; 63(2):446-455. PubMed ID: 37216917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal arthritides - gout and calcium pyrophosphate arthritis : Part 1: Epidemiology and pathophysiology.
    Schlee S; Bollheimer LC; Bertsch T; Sieber CC; Härle P
    Z Gerontol Geriatr; 2018 Jun; 51(4):453-460. PubMed ID: 28233117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal arthritis: a clinician's view.
    Hall S
    Aust Fam Physician; 1991 Dec; 20(12):1717-24. PubMed ID: 1805773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of anakinra in calcium pyrophosphate crystal-induced arthritis: a report of 16 cases and review of the literature.
    Ottaviani S; Brunier L; Sibilia J; Maurier F; Ardizzone M; Wendling D; Gill G; Palazzo E; Meyer O; Dieudé P
    Joint Bone Spine; 2013 Mar; 80(2):178-82. PubMed ID: 23022422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium crystal deposition diseases: update on pathogenesis and manifestations.
    Molloy ES; McCarthy GM
    Rheum Dis Clin North Am; 2006 May; 32(2):383-400, vii. PubMed ID: 16716885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.